These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 8158817

  • 21. Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more.
    Scheifele DW, Bjornson GJ.
    CMAJ; 1993 Feb 15; 148(4):551-5. PubMed ID: 8431816
    [Abstract] [Full Text] [Related]

  • 22. Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine.
    Vidor E, Xueref C, Blondeau C, Bajard A, Francon A, Goudeau A, Peyron F, Brasseur P, Zuckerman A.
    Biologicals; 1996 Sep 15; 24(3):235-42. PubMed ID: 8978923
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial.
    Mayorga Pérez O, Herzog C, Zellmeyer M, Loáisiga A, Frösner G, Egger M.
    J Infect Dis; 2003 Sep 01; 188(5):671-7. PubMed ID: 12934183
    [Abstract] [Full Text] [Related]

  • 24. Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans.
    Ran LA, Wang DZ, Duan QY, Yan TY, Liu QL, Luo YG, Yang DZ, Yang DF, Xiao Z, Xie QJ.
    Chin Med J (Engl); 1993 Aug 01; 106(8):604-7. PubMed ID: 8222910
    [Abstract] [Full Text] [Related]

  • 25. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
    Dagan R, Greenberg D, Weber F.
    Vaccine; 2005 Oct 25; 23(44):5144-8. PubMed ID: 16043271
    [Abstract] [Full Text] [Related]

  • 26. Effect of hepatitis A vaccination schedules on immune response.
    Tilzey AJ, Palmer SJ, Barrow S, Perry KR, Tyrell H, Safary A, Banatvala JE.
    Vaccine; 1992 Oct 25; 10 Suppl 1():S121-3. PubMed ID: 1335640
    [Abstract] [Full Text] [Related]

  • 27. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Davidson M, Krugman S, Sandman LA.
    Vaccine; 1992 Oct 25; 10 Suppl 1():S119-20. PubMed ID: 1335639
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the reactogenicity and immunogenicity of two different dose levels of hepatitis A vaccine in healthy children and adolescents.
    Poovorawan Y, Kosuwon P, Sutra S, Theamboonlers A, Vimolket T, Safary A.
    Asian Pac J Allergy Immunol; 1998 Oct 25; 16(2-3):111-7. PubMed ID: 9876949
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hepatitis A vaccines.
    Wkly Epidemiol Rec; 2000 Feb 04; 75(5):38-44. PubMed ID: 10693358
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.
    Guan R, Ng HS, Fock KM, Ho KY, Yap I, Kang JY, Chow WC, Chew CN, Ng C, Teo CJ.
    Southeast Asian J Trop Med Public Health; 1995 Jun 04; 26(2):268-71. PubMed ID: 8629058
    [Abstract] [Full Text] [Related]

  • 36. [A trial of a cultured inactivated vaccine against hepatitis A on Saguinus mystax tamarins].
    Poleshchuk VF, Balaian MS, Sobol' AV, Titova IP, Guliaeva TV, Dokin VP, Kusov IuIu.
    Vopr Virusol; 1990 Jun 04; 35(4):296-9. PubMed ID: 2256314
    [Abstract] [Full Text] [Related]

  • 37. [Characteristics of reactogenic and immunogenic properties of the children's variant of the domestic vaccine, "Gep-A-in-Vak", against hepatitis A].
    Ikoev VN, Gorbunov MA, Maĭdaniuk AG, Karpovich LG, Kalashnikova TV, Bektimirov TA, Karpova EV, Nemtsov IuV, Muntlieva MA, Kriuk NI.
    Vopr Virusol; 1999 Jun 04; 44(3):133-6. PubMed ID: 10392439
    [Abstract] [Full Text] [Related]

  • 38. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings.
    André FE, D'Hondt E, Delem A, Safary A.
    Vaccine; 1992 Jun 04; 10 Suppl 1():S160-8. PubMed ID: 1335652
    [Abstract] [Full Text] [Related]

  • 39. Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine.
    Goubau P, Van Gerven V, Safary A, Delem A, Knops J, D'Hondt E, André FE, Desmyter J.
    Vaccine; 1992 Jun 04; 10 Suppl 1():S114-8. PubMed ID: 1335638
    [Abstract] [Full Text] [Related]

  • 40. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine.
    McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L.
    Arch Pediatr Adolesc Med; 1996 Jul 04; 150(7):733-9. PubMed ID: 8673200
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.